{"id":"https://openalex.org/W4361847637","doi":"https://doi.org/10.1158/0008-5472.22401329","title":"Supplementary Figures 1 - 7 from CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy","display_name":"Supplementary Figures 1 - 7 from CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4361847637","doi":"https://doi.org/10.1158/0008-5472.22401329"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22401329","doi":"https://doi.org/10.1158/0008-5472.22401329","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22401329","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/0008-5472.22401329","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055708371","display_name":"Yuting Ma","orcid":"https://orcid.org/0000-0001-6267-1852","observed_orcids":["https://orcid.org/0000-0001-6267-1852","https://orcid.org/0000-0002-0905-6639"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuting Ma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047030847","display_name":"Stephen R. Mattarollo","orcid":"https://orcid.org/0000-0003-3659-6507","observed_orcids":["https://orcid.org/0000-0003-3659-6507"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen R. Mattarollo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048555847","display_name":"Sandy Adjemian","orcid":"https://orcid.org/0000-0001-5594-5499","observed_orcids":["https://orcid.org/0000-0001-5594-5499"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandy Adjemian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013437001","display_name":"Heng Yang","orcid":"https://orcid.org/0000-0002-1491-4490","observed_orcids":["https://orcid.org/0000-0002-1491-4490"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heng Yang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091546512","display_name":"Laetitia Aymeric","orcid":"https://orcid.org/0000-0001-7459-7231","observed_orcids":["https://orcid.org/0000-0001-7459-7231"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laetitia Aymeric","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038255372","display_name":"Dalil Hannani","orcid":"https://orcid.org/0000-0001-5097-1401","observed_orcids":["https://orcid.org/0000-0001-5097-1401"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dalil Hannani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008056633","display_name":"Jo\u00e3o Paulo Portela Catani","orcid":"https://orcid.org/0000-0002-4866-3933","observed_orcids":["https://orcid.org/0000-0002-4866-3933"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jo\u00e3o Paulo Portela Catani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040640951","display_name":"Helene Duret","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helene Duret","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007330428","display_name":"Michele W.L. Teng","orcid":"https://orcid.org/0000-0003-1886-9145","observed_orcids":["https://orcid.org/0000-0003-1886-9145"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michele W.L. Teng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056768522","display_name":"Oliver Kepp","orcid":"https://orcid.org/0000-0002-6081-9558","observed_orcids":["https://orcid.org/0000-0002-6081-9558"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oliver Kepp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100604312","display_name":"Yidan Wang","orcid":"https://orcid.org/0009-0001-5890-0672","observed_orcids":["https://orcid.org/0009-0001-5890-0672"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yidan Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065469646","display_name":"Antonella Sistigu","orcid":"https://orcid.org/0000-0002-2528-1238","observed_orcids":["https://orcid.org/0000-0002-2528-1238"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonella Sistigu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073445890","display_name":"Joachim Ludwig Schultze","orcid":"https://orcid.org/0000-0003-2812-9853","observed_orcids":["https://orcid.org/0000-0003-2812-9853"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joachim L. Schultze","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063687089","display_name":"Gautier Stoll","orcid":"https://orcid.org/0000-0002-0862-4139","observed_orcids":["https://orcid.org/0000-0002-0862-4139"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gautier Stoll","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071827163","display_name":"Lorenzo Galluzzi","orcid":"https://orcid.org/0000-0003-2257-8500","observed_orcids":["https://orcid.org/0000-0003-2257-8500"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lorenzo Galluzzi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074612242","display_name":"Laurence Zitvogel","orcid":"https://orcid.org/0000-0003-1596-0998","observed_orcids":["https://orcid.org/0000-0003-1596-0998"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laurence Zitvogel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061575707","display_name":"Mark John Smyth","orcid":"https://orcid.org/0000-0001-7098-7240","observed_orcids":["https://orcid.org/0000-0001-7098-7240"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark J. Smyth","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5075296559","display_name":"Guido Kroemer","orcid":"https://orcid.org/0000-0002-9334-4405","observed_orcids":["https://orcid.org/0000-0002-9334-4405"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guido Kroemer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.5687999725341797,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.5687999725341797,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.40720000863075256,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ccl2-ccr2","display_name":"CCL2/CCR2","score":0.9089999794960022},{"id":"https://openalex.org/keywords/anthracycline-based-chemotherapy","display_name":"anthracycline chemotherapy","score":0.9279999732971191},{"id":"https://openalex.org/keywords/myeloid-cells","display_name":"myeloid cells","score":0.8640000224113464},{"id":"https://openalex.org/keywords/macrophage-polarization","display_name":"macrophage polarization","score":0.7580000162124634},{"id":"https://openalex.org/keywords/antigen-specific-t-cells","display_name":"antigen-specific T cells","score":0.8709999918937683},{"id":"https://openalex.org/keywords/tumor-draining-lymph-nodes","display_name":"tumor-draining lymph nodes","score":0.8679999709129333},{"id":"https://openalex.org/keywords/chemokine-expression","display_name":"chemokine expression","score":0.7590000033378601},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.4950000047683716}],"concepts":[{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.7244682312011719},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6878839731216431},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5546266436576843},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.46938464045524597},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4568645656108856},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4433589279651642},{"id":"https://openalex.org/C101666144","wikidata":"https://www.wikidata.org/wiki/Q2587862","display_name":"CCL2","level":4,"score":0.4225197732448578},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.42147600650787354},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3416537344455719},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3332982659339905},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2590751051902771},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.22797584533691406},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1555875837802887},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.04891079664230347}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/0008-5472.22401329","doi":"https://doi.org/10.1158/0008-5472.22401329","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22401329","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/0008-5472.22401329.v1","doi":"https://doi.org/10.1158/0008-5472.22401329.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22401329.v1","pdf_url":"https://aacr.figshare.com/ndownloader/files/39847118","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22401329","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figures_1_-_7_from_CCL2_CCR2-Dependent_Recruitment_of_Functional_Antigen-Presenting_Cells_into_Tumors_upon_Chemotherapy/22401329","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22401329","doi":"https://doi.org/10.1158/0008-5472.22401329","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22401329","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361847637.pdf","grobid_xml":"https://content.openalex.org/works/W4361847637.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361822847","https://openalex.org/W1990788258","https://openalex.org/W2038218697","https://openalex.org/W4231112787","https://openalex.org/W4392488559","https://openalex.org/W344002347","https://openalex.org/W2732666488","https://openalex.org/W1424517657","https://openalex.org/W4392685186","https://openalex.org/W2569090251"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"544K,":[3],"Influence":[4],"of":[5,17,22,49,67,77,85],"anthracycline-based":[6],"chemotherapy":[7,18,33,43,60],"on":[8,19,87],"myeloid":[9,69],"cells":[10,30,37,52,89,93],"in":[11,63],"distinct":[12],"lymphoid":[13],"organs":[14],"(S1);":[15],"Impact":[16],"the":[20,47,64,75],"expression":[21,76],"M1":[23],"and":[24,90],"M2":[25],"macrophage-related":[26],"genes":[27,79],"by":[28,80],"Ly6Chigh":[29],"(S2);":[31],"Anthracycline-based":[32,42,59],"activates":[34],"antigen-specific":[35,50],"T":[36,51],"within":[38,53],"neoplastic":[39],"lesions":[40],"(S3);":[41],"fails":[44],"to":[45],"affect":[46],"proliferation":[48],"tumor":[54],"draining":[55],"lymph":[56],"nodes":[57],"(S4);":[58],"induces":[61],"fluctuations":[62],"circulating":[65],"levels":[66],"various":[68],"cell":[70],"populations":[71],"(S5);":[72],"Chemotherapy":[73],"regulates":[74],"chemokine-encoding":[78],"tumor-infiltrating":[81,91],"leukocytes":[82],"(S6);":[83],"Expression":[84],"Ccr2":[86],"malignant":[88],"CD11b+":[92],"(S7).":[94]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}